Alphabet no longer has a controlling stake in its life sciences business Verily

Alphabet Verily’s life sciences business is restructuring and raising funds as a new legal entity. Verily announced that with its $300 million investment round, it would transition from an LLC to a corporation and rename itself Verily Health Inc. As a result, Alphabet now has a minority rather than majority stake in the company.

Similar to every other tech company, this chapter of Verily will be focused on AI. “From research to care, our customers need solutions that combine the best of clinical and scientific rigor with AI to deliver the next generation of healthcare that is as precise as it is personal,” said Stephen Gillett, President and CEO.

Google Life Sciences was renamed Verily in 2015, around the same time Google was also renamed Alphabet. Over the years, the organization has worked on a wide range of projects, such as using eye devices to predict heart disease and an opioid addiction center. In 2025, it closed its medical devices division, a move that may have marked its shift toward AI.